Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
Amid the war in Iran and other international conflicts, the U.S. State Department continues to update its travel advisories for American citizens, revealing the latest list ahead of April travel....
USDC adoption hinges on volume, not circulation, the bank said ...
Militants have killed Nigerian soldiers in an ambush in Kebbi state amid escalating violence linked to bandits and Islamic State groups...
